Why the study?
Understanding carotid body hypoxia, cellular transduction, and intercellular signalling mechanisms is crucial for identifying novel interventions to reduce carotid body hyperactivity in cardiometabolic diseases.
Answers are grounded in this paper and cite their sources.
The carotid body acts as a key sensor for oxygen and glucose, presenting a potential therapeutic target for modulating autonomic dysfunction in cardiometabolic diseases and hypertension.
On its activation, the carotid body (CB) provides one of the greatest stimulants to raise cardiovascular sympathetic activity. Through proof of principle studies the CB has been shown to be a major driver of the heightened sympathetic activity associated with several cardiometabolic diseases. Understanding the mechanisms of hypoxia and cellular transduction as well as inter-cellular signalling within the CB becomes crucial for identification of novel interventions to quench CB hyperactivity in disease. In this review, we summarise the mechanisms of hypoxia but also emphasise that the CB is more than an oxygen sensor which is acutely tuned to the regulation of both oxygen and glucose with feedback from blood-borne hormones regulating metabolism. This feature opens new druggable targets to restrain CB activity as well as the possibility to consider this organ as a nodal point for regulating autonomic dysfunction underpinning the metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) conducted a review in Hypertension and cardiometabolic diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: